ANALYSIS OF MECHANISMS OF EARLY HAEMATOPOIETIC STEM CELL DEVELOPMENT CONTROLLED BY FLK1/SCL REGULATORY NETWORK
FLK1/SCL调控网络调控早期造血干细胞发育机制分析
基本信息
- 批准号:G0900962/1
- 负责人:
- 金额:$ 158.35万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2010
- 资助国家:英国
- 起止时间:2010 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The blood system in the animal is maintained through daily generation of billions of different types of erythrocytes, granulocytes and lymphocytes. At the foundation of the blood system lie blood stem cells called haematopoietic stem cells (HSC). Thus, all blood cells in the animal are generated from HSCs. This is the cell type which is responsible for the long-term reconstitution of the blood system of patients who receive bone marrow transplants. Since the number of bone marrow donors is limited, scientists and clinicians are seeking for alternative routes for generation of HSCs in the laboratory conditions. Embryonic stem (ES) cells hold a great promise for regenerative medicine, including production of blood. However, the generation of HSCs from ES cells pose a serious challenge, mainly because many essential details of how the embryo generates HSCs are missing.To a large extent, the progress has been slow since no culture system which would allow us to replicate development of HSCs was available until recently. This research proposal is mainly based on a novel powerful and analytical culture system developed in our laboratory. It allowed us to identify specific stages of development of HSCs in the embryo, at a time when these stages are concealed from scrutiny by traditional methods. We will use this culture system to investigate two genes, called Flk1 and Scl, that are, major regulators of early HSC development. These genes are expressed in various populations of cells of the developing embryo which are potentially involved in development of HSCs. In addition, these genes have a potential to regulate each other?s activity. We will study how Flk1 and Scl genes regulate stages of HSC development by deleting these genes in our culture system using modern recombination technology. Results of such gene ablation will always be verified by a long-term transplantation assay, which is the gold-standard approach for detection of the presence and numbers of HSCs. Additionally, we will carry out more comprehensive analysis of genes expressed at different stages of HSC development and determine how this genetic regulatory network is modified after deletion of Flk1 and Scl. To this end, we will use a modern automated system called Solexa. This approach will allow us to create a computerised genetic network which is involved in early generation of HSCs. In the longer term, this model will be a useful resource for testing the role of other genes in development of HSCs.
动物中的血液系统是通过每天每天产生数十亿种不同类型的红细胞,粒细胞和淋巴细胞来维持的。血液系统的基础是血管干细胞,称为造血干细胞(HSC)。因此,动物中的所有血细胞都是由HSC产生的。这是负责接受骨髓移植的患者血液系统长期重构的细胞类型。由于骨髓供体的数量有限,因此科学家和临床医生正在寻求在实验室条件下产生HSC的替代途径。胚胎干细胞(ES)细胞对再生医学(包括血液的产生)具有巨大的希望。但是,从ES细胞产生的HSC产生构成了一个严重的挑战,主要是因为胚胎如何缺少胚胎的许多基本细节。直到最近才能使用HSC。该研究建议主要基于我们实验室开发的新型强大而分析的培养系统。它使我们能够确定胚胎中HSC的特定发展阶段,而传统方法对这些阶段进行了审查。我们将使用该培养系统来研究两个称为FLK1和SCL的基因,即早期HSC开发的主要调节剂。这些基因在发育中的胚胎的各种细胞中表达,这些细胞可能参与HSC的发展。另外,这些基因有可能相互调节的活性。我们将研究FLK1和SCL基因如何使用现代重组技术在我们的培养系统中删除这些基因来调节HSC开发的阶段。这种基因消融的结果将始终通过长期移植测定法验证,这是检测HSC存在和数量的金标准方法。此外,我们将对在HSC开发的不同阶段表达的基因进行更全面的分析,并确定在删除FLK1和SCL后如何修改该遗传调节网络。为此,我们将使用一个名为Solexa的现代自动化系统。这种方法将使我们能够创建一个与早期HSC相关的计算机化遗传网络。从长远来看,该模型将是测试其他基因在HSC开发中的作用的有用资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Medvinsky其他文献
Alexander Medvinsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Medvinsky', 18)}}的其他基金
Validation of biomarkers predicting clinical outcomes of umbilical cord blood transplantation
预测脐带血移植临床结果的生物标志物的验证
- 批准号:
MR/W029669/1 - 财政年份:2023
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
Analysis of biomechanical forces in the embryonic development of haematopoietic stem cells
造血干细胞胚胎发育过程中的生物力学力分析
- 批准号:
BB/W003236/1 - 财政年份:2022
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
UNDERSTANDING MOLECULAR MECHANISMS UNDERLYING DEVELOPMENT OF HIGHLY REGENERATIVE HUMAN HAEMATOPOIETIC STEM CELLS
了解高度再生人类造血干细胞发育的分子机制
- 批准号:
MR/V030043/1 - 财政年份:2021
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
IDENTIFICATION OF A NOVEL ANGIOPOIETIN 2 SIGNALLING CENTRE IN THE EMBRYONIC HAEMATOPOIETIC STEM CELL NICHE
胚胎造血干细胞生态位中新型血管生成素 2 信号中心的鉴定
- 批准号:
MR/R018081/1 - 财政年份:2018
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
Tracking the embryonic origin of the adult haematopoietic system
追踪成人造血系统的胚胎起源
- 批准号:
MR/L018160/1 - 财政年份:2014
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
DEVELOPMENT OF A NON-INVASIVE STRATEGY ENHANCING HAEMATOPOIETIC STEM CELL (HSC) POTENTIAL OF HUMAN UMBILICAL CORD CELLS
开发增强人类脐带细胞造血干细胞 (HSC) 潜力的非侵入性策略
- 批准号:
G0901577/1 - 财政年份:2011
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
Identification of functional domains in the AGM region linked to the hierarchical organisation of the developing haematopoietic stem cell lineage
鉴定与发育中的造血干细胞谱系的层次结构相关的 AGM 区域的功能域
- 批准号:
BB/H008780/1 - 财政年份:2010
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
Role of AML1/Runx1 isoforms in development, self-renewal and differentiation of haematopoietic progenitor/stem cells
AML1/Runx1亚型在造血祖细胞/干细胞发育、自我更新和分化中的作用
- 批准号:
G0500950/1 - 财政年份:2006
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
The analysis of cellular mechanisms underlying haematopoietic stem cell (HSC) development using a novel in vitro system
使用新型体外系统分析造血干细胞 (HSC) 发育的细胞机制
- 批准号:
BB/D01347X/1 - 财政年份:2006
- 资助金额:
$ 158.35万 - 项目类别:
Research Grant
相似国自然基金
单细胞拟时序分析揭示结直肠癌异时性肝转移的早期血清标志物谱及转移定植机制研究
- 批准号:82372336
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于TCR分析的allo-HSCT后早期T细胞免疫重建与aGVHD发生的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于纹理分析及NMR代谢组学的糖尿病肌少症骨骼肌干细胞早期损伤机制研究
- 批准号:81801670
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
生命早期环境暴露与不良妊娠结局风险的区域差异及作用机制
- 批准号:41871360
- 批准年份:2018
- 资助金额:58.0 万元
- 项目类别:面上项目
条斑紫菜早期发育阶段响应盐度胁迫的生理生化过程分析
- 批准号:41806166
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
- 批准号:
10722515 - 财政年份:2023
- 资助金额:
$ 158.35万 - 项目类别:
Resilience to cognitive decline and resistance to Alzheimer's disease and related neurodegenerative diseases in individuals from Colombia with autosomal dominant dementias
哥伦比亚常染色体显性痴呆患者对认知能力下降的抵抗力以及对阿尔茨海默病和相关神经退行性疾病的抵抗力
- 批准号:
10721433 - 财政年份:2023
- 资助金额:
$ 158.35万 - 项目类别:
Prenatal Extracellular Vesicles and Steroid Hormones as Biological Mechanisms Underlying Gestational Factors Associated with Neurodevelopmental Risk
产前细胞外囊泡和类固醇激素作为与神经发育风险相关的妊娠因素的生物机制
- 批准号:
10739066 - 财政年份:2023
- 资助金额:
$ 158.35万 - 项目类别:
Mechanisms underlying age-based stereotype threat effects
基于年龄的刻板印象威胁效应的潜在机制
- 批准号:
10727593 - 财政年份:2023
- 资助金额:
$ 158.35万 - 项目类别:
Osteocyte-dependent mechanisms of bone cartilage crosstalk in osteoarthritis
骨关节炎中骨软骨串扰的骨细胞依赖性机制
- 批准号:
10727267 - 财政年份:2023
- 资助金额:
$ 158.35万 - 项目类别: